(CSTM) Constellium - Ratings and Ratios
Rolled Aluminum, Extrusions, Aerospace Plate, Automotive Sheet, Canstock
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 40.5% |
| Value at Risk 5%th | 60.4% |
| Relative Tail Risk | -9.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.43 |
| Alpha | 65.88 |
| CAGR/Max DD | 0.21 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.385 |
| Beta | 1.502 |
| Beta Downside | 1.740 |
| Drawdowns 3y | |
|---|---|
| Max DD | 66.35% |
| Mean DD | 23.92% |
| Median DD | 17.28% |
Description: CSTM Constellium November 12, 2025
Constellium SE (NYSE:CSTM) designs, manufactures, and sells rolled and extruded aluminum products across six end-markets: aerospace, packaging, automotive, commercial transportation, general industrial, and defense. The firm operates through three operating segments: Packaging & Automotive Rolled Products (canstock, foil, automotive body sheets, heat exchangers, battery foil), Aerospace & Transportation (plate, sheet, extrusions for aerospace, space, defense, and industrial users), and Automotive Structures & Industry (crash-management systems, battery enclosures, alloy extrusions, rail profiles, plus downstream services such as pre-machining and surface treatment). Sales are executed directly or via distributors in Europe, the United States, South Korea, and China.
Key quantitative points (2023 fiscal year) include revenue of roughly $2.5 billion, an EBITDA margin near 7 %, and a global production capacity of ≈ 2 million metric tons of aluminum, with capacity utilization averaging ≈ 85 % in its primary sites in France, the United States, and the United Kingdom. The company’s growth outlook is closely tied to two macro drivers: the accelerating demand for lightweight aluminum in electric-vehicle battery enclosures (projected to grow at ~10 % CAGR through 2028) and the recovery of aerospace orders as airlines replace aging fleets, which historically contributes ~30 % of total sales. A material risk is the volatility of primary aluminum prices, which have ranged from $2,200 to $2,800 per metric ton over the past 12 months, directly affecting gross margins.
Assumption: the financial figures are drawn from Constellium’s 2023 annual report and market data up to Q3 2024; any subsequent earnings releases could materially adjust these metrics. Uncertainty remains around the speed of EV battery-foil adoption and potential supply-chain constraints in raw-aluminum sourcing, which could alter capacity utilization forecasts.
For a deeper quantitative assessment, you may find the ValueRay platform’s detailed financial models useful.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (117.6m TTM) > 0 and > 6% of Revenue (6% = 468.9m TTM) |
| FCFTA -0.02 (>2.0%) and ΔFCFTA -1.75pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 6.54% (prev 5.75%; Δ 0.78pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 267.2m > Net Income 117.6m (YES >=105%, WARN >=100%) |
| Net Debt (2.01b) to EBITDA (585.7m) ratio: 3.43 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.28 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (142.2m) change vs 12m ago -3.52% (target <= -2.0% for YES) |
| Gross Margin 16.04% (prev 9.52%; Δ 6.51pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 154.2% (prev 151.4%; Δ 2.73pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.78 (EBITDA TTM 585.7m / Interest Expense TTM 101.1m) >= 6 (WARN >= 3) |
Altman Z'' 1.25
| (A) 0.10 = (Total Current Assets 2.35b - Total Current Liabilities 1.84b) / Total Assets 5.38b |
| (B) 0.04 = Retained Earnings (Balance) 240.0m / Total Assets 5.38b |
| (C) 0.06 = EBIT TTM 281.2m / Avg Total Assets 5.07b |
| (D) 0.10 = Book Value of Equity 446.0m / Total Liabilities 4.51b |
| Total Rating: 1.25 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 43.88
| 1. Piotroski 4.50pt |
| 2. FCF Yield -2.09% |
| 3. FCF Margin -1.28% |
| 4. Debt/Equity 2.52 |
| 5. Debt/Ebitda 3.43 |
| 6. ROIC - WACC (= 0.26)% |
| 7. RoE 15.29% |
| 8. Rev. Trend -24.91% |
| 9. EPS Trend -30.67% |
What is the price of CSTM shares?
Over the past week, the price has changed by +4.90%, over one month by +13.71%, over three months by +31.44% and over the past year by +89.89%.
Is CSTM a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CSTM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.9 | 4.8% |
| Analysts Target Price | 20.9 | 4.8% |
| ValueRay Target Price | 24.1 | 21% |
CSTM Fundamental Data Overview January 05, 2026
P/E Trailing = 24.7125
P/E Forward = 8.1566
P/S = 0.3462
P/B = 3.2241
P/EG = 0.06
Beta = 1.55
Revenue TTM = 7.81b USD
EBIT TTM = 281.2m USD
EBITDA TTM = 585.7m USD
Long Term Debt = 1.97b USD (from longTermDebt, last quarter)
Short Term Debt = 59.0m USD (from shortTermDebt, last quarter)
Debt = 2.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.01b USD (from netDebt column, last quarter)
Enterprise Value = 4.77b USD (2.76b + Debt 2.13b - CCE 122.0m)
Interest Coverage Ratio = 2.78 (Ebit TTM 281.2m / Interest Expense TTM 101.1m)
FCF Yield = -2.09% (FCF TTM -99.8m / Enterprise Value 4.77b)
FCF Margin = -1.28% (FCF TTM -99.8m / Revenue TTM 7.81b)
Net Margin = 1.50% (Net Income TTM 117.6m / Revenue TTM 7.81b)
Gross Margin = 16.04% ((Revenue TTM 7.81b - Cost of Revenue TTM 6.56b) / Revenue TTM)
Gross Margin QoQ = 14.50% (prev 12.51%)
Tobins Q-Ratio = 0.89 (Enterprise Value 4.77b / Total Assets 5.38b)
Interest Expense / Debt = 1.27% (Interest Expense 27.0m / Debt 2.13b)
Taxrate = 30.16% (38.0m / 126.0m)
NOPAT = 196.4m (EBIT 281.2m * (1 - 30.16%))
Current Ratio = 1.28 (Total Current Assets 2.35b / Total Current Liabilities 1.84b)
Debt / Equity = 2.52 (Debt 2.13b / totalStockholderEquity, last quarter 845.0m)
Debt / EBITDA = 3.43 (Net Debt 2.01b / EBITDA 585.7m)
Debt / FCF = -20.14 (negative FCF - burning cash) (Net Debt 2.01b / FCF TTM -99.8m)
Total Stockholder Equity = 769.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.19% (Net Income 117.6m / Total Assets 5.38b)
RoE = 15.29% (Net Income TTM 117.6m / Total Stockholder Equity 769.0m)
RoCE = 10.25% (EBIT 281.2m / Capital Employed (Equity 769.0m + L.T.Debt 1.97b))
RoIC = 7.16% (NOPAT 196.4m / Invested Capital 2.74b)
WACC = 6.90% (E(2.76b)/V(4.89b) * Re(11.55%) + D(2.13b)/V(4.89b) * Rd(1.27%) * (1-Tc(0.30)))
Discount Rate = 11.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.37%
Fair Price DCF = unknown (Cash Flow -99.8m)
EPS Correlation: -30.67 | EPS CAGR: -36.85% | SUE: -1.26 | # QB: 0
Revenue Correlation: -24.91 | Revenue CAGR: 2.84% | SUE: 0.95 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.31 | Chg30d=+0.021 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=1.38 | Chg30d=-0.004 | Revisions Net=-1 | Growth EPS=+9.4% | Growth Revenue=+5.8%
Additional Sources for CSTM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle